Assessment Outcomes Related to Exploring the Interplay between Cardiovascular Disease and Hormonal Changes through Menopause, to Identify the Most Important Preventive Strategies Used in This Study

The proposed study seeks to test the hypothesis that hormonal variations occurring during menopause are linked with the development of cardiovascular disease, and also test the effectiveness of preventive measures, among women where The research employed a cross-sectional study methodology and included a sample of 104 women who had already reached menopause aged 40 to 65 years while The participants were subjected to a series of comprehensive clinical examinations that included evaluation of the levels of gonadal hormones and cardiovascular risk factors. In addition, evaluation of the intensity of symptoms caused by CVD and awareness of risks and means to prevent CVD were tested by a questionnaire as well as A significant decrease in the levels of the hormones was noticed in most participants, who were around 51-55 years old, with estradiol levels reducing to 200pg/ml, along with the decrease of 50pg/ml increments (p < 0.01) also significant section of the participants had cardiovascular risk factors, such as hypertension (43.3%) and dyslipidemia (28.8%), although the prevalence of CVD was appreciably higher, with coronary artery disease observed in 24% of the participants and according to The preventive strategies used were lifestyle modification in 57.7%, hormone replacement therapy (HRT) in 24%, and in combination, when used, in addition to significant improvement in quality-of-life assessment at 42-45% groups where finally The study reveals is recommended for the analysis of long-term results and discovery of other intervention models for the improvement of cardiovascular status in the demographic.